<ѻý>Diabetes Drug for Cats Now Approved in Humans Tooѻý> Oral SGLT2 inhibitor bexagliflozin indicated for adults with type 2 diabetes Jan 23, 2023
<ѻý>Sodium Nitrite in Food, Water Tied to Type 2 Diabetes Riskѻý> Observational study serves up "new piece of evidence" for debate over additives Jan 17, 2023
<ѻý>How Many Times Do You Need to Get Out of Your Chair in an Otherwise Sedentary Day?ѻý> Trial tested walking break doses to counter ill effects of prolonged sitting Jan 12, 2023
<ѻý>Type 2 Diabetes Patients Can Also Benefit From Fully Closed-Loop Systemѻý> Users spent twice as much time in target glucose range vs standard insulin therapy, study showed Jan 11, 2023
<ѻý>Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicityѻý> Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
<ѻý>Fixing Heart Failure Workforce Issues: Baby Steps Start This Yearѻý> Pay, curriculum changes proposed to attract more doctors Jan 05, 2023
<ѻý>Dementia Accompanying Cardiometabolic Disease: Does It Come Down to Genetics?ѻý> Twin study suggests special monitoring in some individuals Dec 29, 2022
<ѻý>Wegovy OK'd for Teens With Obesityѻý> New indication for popular weight-loss injectable Dec 29, 2022
<ѻý>Competitor Poised to Take on Obesity Treatment Giant Wegovy in 2023ѻý> Both Eli Lilly and Novo Nordisk scramble to rectify supply shortages Dec 28, 2022
<ѻý>The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugsѻý> Treatment no longer limited by ejection fraction Dec 27, 2022
<ѻý>Glycemic Control With Insulin Barely Budged Over the Past 30 Yearsѻý> Rates of hyperglycemia also remained elevated for racial and ethnic minorities Dec 20, 2022
<ѻý>Metformin Protective Against Joint Replacement in Type 2 Diabetesѻý> Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
<ѻý>Fecal Transplant Failed to Boost Effects of Bariatric Surgeryѻý> No impact on weight loss or metabolism compared with placebo, small study found Dec 16, 2022
<ѻý>No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggestsѻý> Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
<ѻý>Innovation Is Critical to Stop Disparities in Diabetes Careѻý> We must explore how new technologies can help Dec 10, 2022
<ѻý>Do Kidney Transplant Medications Supplant IBD Drugs?ѻý> Study shows many patients no longer need drugs to help keep gut disease in check Dec 08, 2022
<ѻý>TAVR at 20: How Much Longer Will Medicare Mandate a Registry?ѻý> Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
<ѻý>Should We Change Target Blood Pressure?ѻý> Harlan Krumholz, MD, reviews cardiovascular studies and proposes ways to rethink patient outcomes Dec 07, 2022 video
<ѻý>Heart Failure From Meth Use: Growing Beast Lurks in the Shadowsѻý> Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
<ѻý>Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumorsѻý> Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
<ѻý>After Major Motorcycle Rallies, More Organs Available for Donationѻý> Study estimated 21% more organ donors, 26% more transplant recipients per day during rallies Nov 28, 2022
<ѻý>Combo Treatment Could Delay Kidney Failure for Years in Nondiabetic CKDѻý> Big benefits projected with SGLT2/RAAS inhibitor combination therapy Nov 23, 2022
<ѻý>Watch for Severe Hypocalcemia in Dialysis Patients on Prolia, FDA Warnsѻý> Agency said potential risk may require more frequent blood calcium monitoring Nov 22, 2022
<ѻý>Treating Obesity Should Be Our Healthcare Moonshotѻý> Behavioral health changes alone will only do so much Nov 21, 2022
<ѻý>FDA Approves First Drug to Delay Onset of Type 1 Diabetesѻý> Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
<ѻý>FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Controlѻý> Advisors see need for alternatives, citing suboptimal efficacy and tolerance of approved options Nov 17, 2022
<ѻý>Early Cardiac Amyloidosis Still Bad News Without Treatmentѻý> Observational study supports treating even asymptomatic patients Nov 16, 2022
<ѻý>After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Expertsѻý> Drug's effect on serum phosphorus "small and of unclear clinical significance," say FDA reviewers Nov 15, 2022
<ѻý>Low-Dose 'Quadpill' Reduces High Blood Pressureѻý> Significantly lower diastolic blood pressure at 12 weeks, U.S.-based study showed Nov 09, 2022
<ѻý>Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertensionѻý> Aprocitentan targets the endothelin pathway, whereas baxdrostat blocks aldosterone production Nov 09, 2022
<ѻý>Saline Goes Head-to-Head With Balanced Crystalloid IV Fluids for Kidney Transplantѻý> Researcher argued saline should be reconsidered as the standard IV fluid used Nov 07, 2022
<ѻý>Upfront ECMO Disappoints for Cardiogenic Shockѻý> High-cost procedure not yet justified as an early strategy Nov 07, 2022
<ѻý>Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefitѻý> Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
<ѻý>Experts Agree Intravenous Iron Shows Promise for Heart Failure Patientsѻý> While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
<ѻý>Earlier Terlipressin May Be Better for HRS-AKI in Acute-on-Chronic Liver Failureѻý> More acute kidney injury reversals at 7 days and lower mortality with initiation at 12 hours Nov 07, 2022
<ѻý>Mixed Results With Alerts for AKI-Related Medications in Hospitalѻý> EHR pings improved outcomes in those on PPIs, but lacked general clinical impact Nov 06, 2022
<ѻý>Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the EDѻý> Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
<ѻý>Diuretics on Par in Head-to-Head Comparison for Hypertensionѻý> But a surprise signal emerges for one group in pragmatic trial Nov 06, 2022
<ѻý>Mixed Results With Pemafibrate in Patients With Type 2 Diabetesѻý> No impact on CV events in PROMINENT; developer brings trial to an end Nov 06, 2022
<ѻý>Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysisѻý> Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022